Skip to main content
. 2020 May 5;18:103. doi: 10.1186/s12916-020-01564-3

Fig. 1.

Fig. 1

Representative coronary artery disease meta-analyses.Most up-to-date and highest quality meta-analyses for coronary artery disease. No individual patient data meta-analyses were available. Trials with routine reperfusion had ≥ 50% of patients receiving thrombolytics or intervention. See Supplemental Figures 3 for full details. IHD, ischaemic heart disease